Overview of RESONATE-2 clinical trial of ibrutinib in CLL
John Gribben et al.
Overview of the RESONATE-2 clinical trial of ibrutinib as front-line therapy
Highlights from ASH 2015 by Alan Burnett, MD on acute myeloid leukemia (AML)
Alan K. Burnett
The EPOCH-R clinical trial in Burkitt lymphoma
The impact of the clinical trial of venetoclax (ABT-199) and obinutuzumab in CLL